V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014455 | 220009007 | 1.76 | 61 | Palliative (P) | 2013-09-11 | 2013-09-15 | Irinotecan + De Gramont | 02 | null | 220033957 | CISPLATIN + GEMCITABINE |
| 220014456 | 220009009 | 1.65 | null | Curative (C) | 2014-06-21 | 2014-06-22 | UKALL14- Ph 2 Induction | N | N | 220033963 | FBC |
| 220014457 | 220014812 | 1.79 | 78 | Palliative (P) | 2015-04-01 | 2016-03-07 | Docetaxel | N | null | 220033963 | IRINOTECAN + MDG |
| 220014458 | 220009014 | 1.73 | 87.4 | Curative (C) | 2014-12-25 | 2014-12-26 | Mitox + Tretinoin Spanish Course 3 | Y | N | 220033983 | MITOXANTRONE |
| 220014459 | 220009016 | 1.78 | 105.7 | Disease modification (D) | null | 2015-12-02 | GemCarbo Days 1+8 | N | N | 220033984 | CISPLATIN + GEMCITABINE |
| 220014460 | 220009018 | null | 80 | null | 2013-09-06 | 2013-09-20 | PONATINIB | 02 | null | 220033988 | CLOFARABINE + CYTARABINE |
| 220014461 | 220014816 | 0 | null | Palliative (P) | 2014-06-30 | 2014-07-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220033990 | CARBOPLATIN + PACLITAXEL |
| 220014462 | 220009025 | 1.74 | 87.1 | Curative (C) | 2017-07-11 | 2017-07-11 | Carboplatin + Etoposide IV 3 day | N | N | 220033993 | CARBOPLATIN + ETOPOSIDE |
| 220014463 | 220009026 | null | null | Curative (C) | 2017-11-30 | 2017-12-17 | ECX | null | Y | 220033997 | CLOFARABINE + CYTARABINE |
| 220014464 | 220009028 | 1.84 | 79 | Disease modification (D) | 2017-04-11 | 2017-05-02 | IDARUBICIN | null | null | 220034002 | IDARUBICIN |
| 220014465 | 220009028 | 1.8 | 90.2 | Palliative (P) | 2018-03-28 | 2018-03-29 | Carboplatin + Etoposide IV 3 day | N | N | 220034002 | CARBOPLATIN + ETOPOSIDE |
| 220014466 | 220009029 | 1.77 | 90.8 | Palliative (P) | 2017-04-28 | 2017-04-29 | ECX | N | N | 220034010 | METHOTREXATE |
| 220014467 | 220009030 | 1.61 | null | Disease modification (D) | null | 2016-07-24 | IDARUBICIN | N | N | 220034012 | IDARUBICIN |
| 220014468 | 220009030 | 1.79 | 67.3 | Curative (C) | 2013-11-17 | 2013-11-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220034012 | CARBOPLATIN + PACLITAXEL |
| 220014469 | 220009030 | 1.7 | 85 | Palliative (P) | 2017-01-08 | 2017-01-24 | Docetaxel 75mg/m2 (21 day) | 2 | N | 220034012 | IRINOTECAN + MDG |
| 220014470 | 220009030 | 1.83 | 93 | Curative (C) | 2016-07-04 | 2016-08-30 | UKALL14- Ph 1 Induction | N | N | 220034012 | GEMCARBO |
| 220014471 | 220009034 | 1.53 | 77 | Palliative (P) | 2014-02-15 | 2014-03-14 | ECX | 2 | N | 220034034 | METHOTREXATE |
| 220014472 | 220009035 | null | 53.8 | Curative (C) | 2015-10-13 | 2016-06-29 | Mitox + Tretinoin Spanish Course 3 | 2 | N | 220034035 | MITOXANTRONE |
| 220014473 | 220019934 | 1.79 | 80.2 | null | 2017-09-14 | 2017-12-30 | IDARUBICIN | N | N | 220034035 | IDARUBICIN |
| 220014474 | 220009037 | 1.76 | 75.5 | Palliative (P) | 2016-08-07 | 2016-08-14 | Docetaxel 75mg/m2 (21 day) | 2 | null | 220034037 | PONATINIB |
| 220014475 | 220009037 | 1.71 | 76.2 | Curative (C) | 2018-04-24 | 2018-04-26 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220034037 | ALEMTUZUMAB |
| 220014476 | 220009039 | null | 85.699 | null | 2015-04-03 | 2015-04-06 | Paclitaxel 7 day | 02 | null | 220034055 | PACLITAXEL |
| 220014477 | 220009042 | 1.31 | 79.3 | Curative (C) | 2013-10-02 | 2014-02-25 | Alemtuzumab cond (RI ALLO CAMP100) | Y | N | 220034061 | ALEMTUZUMAB |
| 220014478 | 220009043 | 1.69 | 90.9 | Palliative (P) | 2017-04-09 | 2017-04-09 | ECX | null | null | 220034064 | PONATINIB |
| 220014479 | 220009044 | 1.6 | 116 | Curative (C) | 2015-10-07 | 2016-07-19 | Oxaliplatin + Modified de Gramont | 2 | N | 220034068 | IRINOTECAN + MDG |
| 220014480 | 220009044 | 1.71 | 75.6 | Palliative (P) | 2014-11-06 | 2014-11-06 | Clofarabine + Cytarabine | 02 | N | 220034068 | IRINOTECAN + MDG |
| 220014481 | 220009047 | 1.54 | 68 | Palliative (P) | 2014-06-18 | 2014-06-18 | Mitoxantrone | N | N | 220034076 | MITOXANTRONE |
| 220014482 | 220009048 | 1.79 | null | Palliative (P) | 2015-01-13 | 2015-04-20 | UKALL 14 TRIAL | N | N | 220034076 | PONATINIB |
| 220014483 | 220009051 | 1.95 | 93.4 | Disease modification (D) | 2014-01-15 | 2014-01-15 | Fludarabine + Melphalan RIC Allo | N | N | 220034081 | DOCETAXEL |
| 220014485 | 220014833 | 1.8 | 108 | Palliative (P) | 2016-11-07 | 2016-11-19 | Irinotecan + Modified De Gramont | null | null | 220034087 | UKALL2014 |
| 220014486 | 220014833 | 1.53 | 70.5 | null | 2013-12-16 | 2013-12-16 | Alemtuzumab cond (RI ALLO CAMP100) | 02 | N | 220034087 | ALEMTUZUMAB |
| 220014487 | 220009056 | 1.55 | 56.2 | Palliative (P) | 2018-10-07 | 2018-10-07 | Mitoxantrone | 2 | N | 220034094 | MITOXANTRONE |
| 220014488 | 220009057 | 1.6 | null | Palliative (P) | 2015-11-09 | 2016-02-08 | Arsenic trioxide + Tretinoin | N | N | 220034101 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014489 | 220009059 | 1.77 | 85 | null | 2016-06-09 | 2016-06-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220034109 | PACLITAXEL |
| 220014490 | 220009060 | 1.83 | 90.6 | Disease modification (D) | 2016-06-09 | 2016-09-29 | FLUOROURACIL + OXALIPLATIN | 02 | N | 220034115 | METHOTREXATE |
| 220014491 | 220009064 | 1.73 | 75.6 | Palliative (P) | 2013-08-12 | 2013-08-12 | PONATINIB | Y | null | 220034117 | METHOTREXATE |
| 220014492 | 220014837 | 1.75 | 63 | null | 2018-01-19 | 2018-01-19 | Clofarabine + Cytarabine | N | N | 220034127 | ECX |
| 220014493 | 220009071 | null | 79.3 | Not known (9) | 2017-02-27 | 2017-03-08 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 220034129 | GEMCARBO |
| 220014494 | 220009072 | 1.85 | 61.1 | Adjuvant (A) | 2017-04-08 | 2017-12-14 | CARBOPLATIN + ETOPOSIDE | 2 | N | 220034129 | CARBOPLATIN + ETOPOSIDE |
| 220014495 | 220009074 | 1.55 | 108.4 | Palliative (P) | 2013-06-23 | 2013-06-26 | Mitoxantrone | 02 | N | 220034136 | MITOXANTRONE |
| 220014496 | 220009075 | 1.55 | 50.15 | Palliative (P) | null | 2016-06-09 | Cytarabine intrathecal | N | N | 220034140 | CYTARABINE INTRATHECAL |
| 220014497 | 220009075 | 1.73 | 86.5 | Palliative (P) | 2014-01-04 | 2014-01-04 | Irinotecan + Modified De Gramont | N | N | 220034140 | FBC |
| 220014498 | 220009077 | null | 72.2 | Palliative (P) | 2014-03-12 | 2014-04-20 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220034152 | UKALL2014 |
| 220014499 | 220014840 | 1.7 | 69 | Palliative (P) | 2014-10-03 | 2014-11-12 | GEMTUZUMAB OZOGAMICIN | 2 | N | 220034155 | GEMCARBO |
| 220014500 | 220009078 | 1.6 | 84.9 | Palliative (P) | 2016-03-15 | 2016-06-13 | FLUOROURACIL + OXALIPLATIN | N | N | 220034156 | GEMTUZUMAB OZOGAMICIN |
| 220014501 | 220014841 | 1.69 | 66 | Palliative (P) | 2018-02-15 | 2018-05-11 | Carboplatin + Etoposide IV 3 day | N | N | 220034164 | CARBOPLATIN + ETOPOSIDE |
| 220014503 | 220009083 | 1.74 | 57.5 | Curative (C) | 2017-05-11 | 2017-05-15 | Arsenic trioxide + Tretinoin | 2 | N | 220034177 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014504 | 220009084 | 1.68 | null | Palliative (P) | 2014-09-19 | 2014-10-14 | Carboplatin + Etoposide iv&po | N | N | 220034177 | CARBOPLATIN + ETOPOSIDE |
| 220014505 | 220009084 | 1.78 | 87.4 | Curative (C) | 2016-08-17 | 2016-08-20 | Clofarabine + Cytarabine | 1 | N | 220034177 | UKALL2014 |
| 220014506 | 220009087 | 1.68 | 72.9 | Palliative (P) | 2017-03-14 | 2017-04-25 | Carboplatin + Etoposide IV 3 day | 2 | N | 220034195 | CARBOPLATIN + ETOPOSIDE |